Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices – United States, 2025

This report describes CDC’s recommendation for use of clesrovimab for prevention of severe respiratory syncytial virus (RSV) in infants.

Comments are closed here.